MEFDATE 250MG/250MG TABLET
Marketer
Anvik Biotech
Salt Composition
Ethamsylate (250mg) + Mefenamic Acid (250mg)
Overview MEFDATE 250MG/250MG TABLET
Combiflo 250mg/250mg tablets are used to manage hemorrhaging. This medication functions by stabilizing blood clots and mitigating heavy menstrual bleeding. For optimal gastrointestinal tolerance, administer Combiflo 250mg/250mg tablets with food, adhering to a consistent, evenly spaced schedule as directed by your physician. Regular, timed ingestion aids in treatment adherence. Dosage and treatment length are condition-specific. Complete the prescribed course, regardless of symptom improvement. Potential side effects include skin rashes, headaches, nausea, and anorexia. While typically mild, persistent or bothersome effects warrant medical consultation. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, or if you are pregnant or lactating. Dizziness may occur; avoid operating vehicles or machinery if affected. Disclose all concurrent medications to your healthcare provider due to potential drug interactions.
Primary Ingredients of MEFDATE 250MG/250MG TABLET
No information provided. Please provide the text you wish to be rewritten.
Uses of MEFDATE 250MG/250MG TABLET
Hemorrhage
Major Benefits of MEFDATE 250MG/250MG TABLET:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The MEFDATE 250MG/250MG TABLET should be administered with a meal.
Common Side effects of MEFDATE 250MG/250MG TABLET:
- Skin rash
- Headache
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
How to use MEFDATE 250MG/250MG TABLET:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The MEFDATE 250MG/250MG TABLET should be administered with a meal.
How MEFDATE 250MG/250MG TABLET works:
Each MEFDATE 250MG/250MG tablet contains ethamsylate and mefenamic acid, two active pharmaceutical ingredients. Ethamsylate, an antifibrinolytic agent, stabilizes blood clots, thus helping manage heavy menstrual bleeding. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, reducing pain and inflammation associated with these prostaglandins.
SAFETY ADVICE
AlcoholUNSAFE
Combining MEFDATE 250MG/250MG TABLETS with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of MEFDATE 250MG/250MG TABLETS during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of MEFDATE 250MG/250MG TABLETS while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking a MEFDATE 250MG/250MG TABLET may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use MEFDATE 250MG/250MG TABLETS cautiously, potentially requiring dosage modification. A physician's consultation is advised. MEFDATE 250MG/250MG TABLETS are contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using MEFDATE 250MG/250MG TABLETS. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take MEFDATE 250MG/250MG TABLET :
Should you forget to take your MEFDATE 250MG/250MG TABLET, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About MEFDATE 250MG/250MG TABLET
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently